At Good Growth Capital, David focuses on GGC’s due diligence in both HealthTech and GreenTech for those companies that have developed and use new materials and assess some of the Hard Sciences deals that have complex supply chains. As an experienced Venture Capitalist, David is critical in the formation and fund administration of Good Growth Capital. He serves on the Board for GGC portfolio companies Ateios and NALA systems.